Announced Thu, 6 Aug · 16:20 IST
Board meeting on Aug 12 to consider Q1 results and subsidiary appointments
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.7%1-day move
₹121.45
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.7-5.6-7.4-9.2-11.0-11.1-4.0+0.5——
Up moveDown movePending
AI summary
Arvaya Healthcare's board will meet on Aug 12, 2026 to approve Q1FY27 unaudited standalone and consolidated results. Agenda also includes material related party transactions, directors report, AGM calling, secretarial reports, and appointments at subsidiary level including Rahul Ravindra Mayur as independent director on three wholly owned subsidiaries, plus Abhiram Ranganath and Salil Shetty as directors on a wholly owned subsidiary. Trading window is closed since July 1.
Likely market impact
Routine quarterly results and subsidiary-level governance changes; watch for results and related party transaction details.